Search research articles
Contact Us
Filters
Showing results (351-360 of 688) with videos related to
Page
of 69
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
April 24, 2021
Serum sodium and eplerenone use in patients with a myocardial infarction and left ventricular dysfunction or heart failure: insights from the EPHESUS trial
Pieter Martens, João Pedro Ferreira, John Vincent, et al.
European Journal of Heart Failure
|
April 21, 2025
Mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction according to body weight
Jawad H Butt, Scott D Solomon, Muthiah Vaduganathan, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
January 4, 2019
Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rate
Ken Lee Chin, Timothy Collier, Stuart Pocock, et al.
JAMA
|
July 15, 2015
Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial
George L Bakris, Bertram Pitt, Matthew R Weir, et al.
The New England Journal of Medicine
|
November 22, 2014
Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors
Matthew R Weir, George L Bakris, David A Bushinsky, et al.
Circulation
|
November 17, 2020
Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes
Gerasimos Filippatos, Stefan D Anker, Rajiv Agarwal, et al.
The New England Journal of Medicine
|
December 2, 2020
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
George L Bakris, Rajiv Agarwal, Stefan D Anker, et al.
Circulation
|
November 15, 2021
Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial
Gerasimos Filippatos, Stefan D Anker, Rajiv Agarwal, et al.
JACC. Heart Failure
|
November 3, 2022
Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes
Gerasimos Filippatos, Stefan D Anker, Bertram Pitt, et al.
Journal of the American College of Cardiology
|
June 6, 2020
Abnormalities of Potassium in Heart Failure: JACC State-of-the-Art Review
João Pedro Ferreira, Javed Butler, Patrick Rossignol, et al.
Page
of 69
Search research articles
Search
Showing results (351-360 of 688) with videos related to
Sort By:
Page
of 69
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
April 24, 2021
Serum sodium and eplerenone use in patients with a myocardial infarction and left ventricular dysfunction or heart failure: insights from the EPHESUS trial
Pieter Martens, João Pedro Ferreira, John Vincent, et al.
European Journal of Heart Failure
|
April 21, 2025
Mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction according to body weight
Jawad H Butt, Scott D Solomon, Muthiah Vaduganathan, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
January 4, 2019
Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rate
Ken Lee Chin, Timothy Collier, Stuart Pocock, et al.
JAMA
|
July 15, 2015
Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial
George L Bakris, Bertram Pitt, Matthew R Weir, et al.
The New England Journal of Medicine
|
November 22, 2014
Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors
Matthew R Weir, George L Bakris, David A Bushinsky, et al.
Circulation
|
November 17, 2020
Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes
Gerasimos Filippatos, Stefan D Anker, Rajiv Agarwal, et al.
The New England Journal of Medicine
|
December 2, 2020
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
George L Bakris, Rajiv Agarwal, Stefan D Anker, et al.
Circulation
|
November 15, 2021
Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial
Gerasimos Filippatos, Stefan D Anker, Rajiv Agarwal, et al.
JACC. Heart Failure
|
November 3, 2022
Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes
Gerasimos Filippatos, Stefan D Anker, Bertram Pitt, et al.
Journal of the American College of Cardiology
|
June 6, 2020
Abnormalities of Potassium in Heart Failure: JACC State-of-the-Art Review
João Pedro Ferreira, Javed Butler, Patrick Rossignol, et al.
Page
of 69